Cartalax
Cartalax is a recovery peptide used in evidence-based, physician-supervised protocols. Use for osteoarthritis, cartilage degeneration, post-joint surgery recovery, and connective tissue restoration.
What is Cartalax?
Short-cycle peptide bioregulator derived from cartilage and connective tissue. Activates chondroblast proliferation, upregulates proteoglycan synthesis, reduces articular inflammation.
Uses & clinical decision logic
Use for osteoarthritis, cartilage degeneration, post-joint surgery recovery, and connective tissue restoration. Run 10-20 day cycles 2-3x/year.
Cartalax dosage & administration
| Vial size | BAC water | Dosing range | Units / dose | Frequency | Route |
|---|---|---|---|---|---|
| 20mg | 2mL | 2-5mg | 20-50 units | 5-7 days/week x 10-20 days | SubQ/IM |
Safety & contraindications
Contraindicated in pregnancy/breastfeeding.
Stacking & combinations
Pairs with BPC-157 for joint recovery; consider adding TB-500 for systemic connective tissue support.
Related peptides
Frequently asked questions
What is Cartalax used for?
Use for osteoarthritis, cartilage degeneration, post-joint surgery recovery, and connective tissue restoration. Run 10-20 day cycles 2-3x/year.
What is the typical Cartalax dosage?
Common dosing ranges from 2-5mg (5-7 days/week x 10-20 days, SubQ/IM). Exact dosing is individualized and set by a licensed physician.
How is Cartalax administered?
Cartalax is typically administered via SubQ/IM.
What are the contraindications for Cartalax?
Contraindicated in pregnancy/breastfeeding.
Build a physician-supervised protocol around your goal — no gatekeeping, real doctors, 503A compounding pharmacies.
Build your protocol →This page is for educational purposes only and is not medical advice. Peptide therapies described here are provided under physician supervision through 503A compounding pharmacies. Many peptides are not FDA-approved for the uses described. Do not start, stop, or change any protocol without consulting a licensed physician.